| Authors: |
Javaid H; Hurdle.bio / Chronomics Ltd., London, UK., Petrescu CC; Hurdle.bio / Chronomics Ltd., London, UK., Schmunk LJ; Hurdle.bio / Chronomics Ltd., London, UK., Monahan JM; Biomodal Ltd, The Trinity Building, Chesterford Business Park, Cambridge, UK., O'Reilly P; Sonrai Analytics Ltd, Queens Road, Belfast, Northern Ireland, UK., Garg M; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., McGirr L; Hurdle.bio / Chronomics Ltd., London, UK., Khasawneh MT; Texas A&M International University, Laredo, Texas, U.S.A., Al Lail M; Texas A&M International University, Laredo, Texas, U.S.A., Ganta D; Texas A&M International University, Laredo, Texas, U.S.A., Stubbs TM; Hurdle.bio / Chronomics Ltd., London, UK., Sun BB; Bristol Myers Squibb, New York, U.S.A., Vitsios D; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Martin-Herranz DE; Hurdle.bio / Chronomics Ltd., London, UK. |
